Stimucor 2.5 Tablet
Stimucor 2.5 Tablet is an anti-cancer medication containing Letrozole, an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen production, thereby slowing or stopping the growth of estrogen-dependent breast cancer cells.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Contains Letrozole, a third-generation non-steroidal aromatase inhibitor
-
Specifically designed for postmenopausal women with breast cancer
-
Effective as adjuvant or neoadjuvant therapy
-
Can help prevent cancer recurrence after surgery
-
Sometimes used off-label for ovarian function suppression in PCOS cases
| Technical Specification |
|
|---|
- 1 Strip: 5 Tablet
-
Reduces estrogen levels to slow or stop hormone-sensitive tumor growth
-
Can reduce the risk of breast cancer recurrence after surgery
-
May help shrink tumors prior to surgical removal
-
Convenient once-daily oral dosage
-
Well-established treatment with proven clinical benefits in breast cancer management
